Correlation Between Phoenix Silicon and SynCore Biotechnology

Can any of the company-specific risk be diversified away by investing in both Phoenix Silicon and SynCore Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phoenix Silicon and SynCore Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Phoenix Silicon International and SynCore Biotechnology Co, you can compare the effects of market volatilities on Phoenix Silicon and SynCore Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phoenix Silicon with a short position of SynCore Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phoenix Silicon and SynCore Biotechnology.

Diversification Opportunities for Phoenix Silicon and SynCore Biotechnology

0.16

Correlation Coefficient

Phoenix Silicon  SynCore Biotechnology

Average diversification

The 3 months correlation between Phoenix and SynCore is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Phoenix Silicon International and SynCore Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SynCore Biotechnology and Phoenix Silicon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phoenix Silicon International are associated (or correlated) with SynCore Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SynCore Biotechnology has no effect on the direction of Phoenix Silicon i.e., Phoenix Silicon and SynCore Biotechnology go up and down completely randomly.

Pair Corralation between Phoenix Silicon and SynCore Biotechnology

Assuming the 90 days trading horizon Phoenix Silicon International is expected to generate 0.95 times more return on investment than SynCore Biotechnology. However, Phoenix Silicon International is 1.05 times less risky than SynCore Biotechnology. It trades about 0.0 of its potential returns per unit of risk. SynCore Biotechnology Co is currently generating about -0.01 per unit of risk. If you would invest  12,850  in Phoenix Silicon International on October 25, 2024 and sell it today you would lose (500.00) from holding Phoenix Silicon International or give up 3.89% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Phoenix Silicon International  vs.  SynCore Biotechnology Co

Phoenix Silicon Inte

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Phoenix Silicon International has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Phoenix Silicon is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

SynCore Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SynCore Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, SynCore Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Phoenix Silicon and SynCore Biotechnology

The main advantage of trading using opposite Phoenix Silicon and SynCore Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phoenix Silicon position performs unexpectedly, SynCore Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SynCore Biotechnology will offset losses from the drop in SynCore Biotechnology's long position.

The idea behind Phoenix Silicon International and SynCore Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..